Case report: Long-term response to a combination of immune checkpoint inhibitors as a single treatment for multiple synchronous cancers: a case study
IntroductionImmune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by enhancing the antitumor immune response. This case describes an 80-year-old male with synchronous multiple primary malignancies (MPMs), including lung metastatic hepatocellular carcinoma (HCC), and non-small cell l...
Saved in:
| Main Authors: | Nour Ghammem, Herve Bischoff, Pascale Chiappa, Laura Somme, Fabien Moinard-Butot |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1487227/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune checkpoint inhibitors in high‐grade upper tract urothelial carcinoma: Paradigm shift emphasizing organ preservation
by: Mahmoud Khalil, et al.
Published: (2024-05-01) -
A case of synchronous primary gastric cancer and primary hepatocellular carcinoma
by: Jayabal Pandiaraja
Published: (2018-01-01) -
Impact of Antibiotics on the Efficacy of Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
by: Do Gyeong Lim, et al.
Published: (2023-12-01) -
Safety and clinical efficacy of immune checkpoint inhibitors in pediatric hepatocellular carcinoma: a case report and review of the literature
by: Xiaoting Zhong, et al.
Published: (2025-08-01) -
Immune Checkpoint Inhibitors in Urothelial Carcinoma (Literature Review)
by: K. V. Menshikov, et al.
Published: (2022-10-01)